We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKIL:NYSESkillsoft Corp. Analysis

Data as of 2026-06-19 - not real-time

$7.51

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical snapshot: SKIL trades at $7.51, comfortably above its 20‑day ($6.87) and 50‑day ($6.92) moving averages but still below the 200‑day ($8.73) benchmark, signaling short‑term momentum in a longer‑term bearish backdrop. The RSI sits at 57.7 (neutral) while the MACD histogram is positive and the signal line is deemed bullish, suggesting a possible near‑term bounce. However, volatility is extreme at over 100% (30‑day) and beta exceeds 1.6, indicating the stock is highly sensitive to market swings.
Fundamental backdrop: Revenue has slipped 4.7% year‑over‑year and margins are deep in the red (operating –7.4%, profit –28.5%). The company carries $582 M of debt against $115 M of cash, with a negative book value per share (‑$8.24) and zero ROE. Forward earnings look modestly positive (forward EPS $4.64) and the forward P/E is ultra‑low at 1.6, but trailing earnings are negative and there is no dividend. Recent material news includes a sizeable RSU grant to the new CFO, hinting at confidence in the turnaround plan, while the Q1 FY27 earnings release is imminent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMAs and bullish MACD hint at a modest upside
  • Imminent Q1 earnings could clarify the revenue trend
  • High volatility and beta raise downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward P/E suggests cheapness if earnings recover
  • Debt load and negative equity limit financial flexibility
  • AI‑native platform offers growth potential but execution is unproven

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Sustained negative margins and cash‑burn raise concern
  • Sector (Education & Training) is relatively defensive but competitive
  • Strategic RSU grant may align leadership with a turnaround plan

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin-28.52%
P/E Ratio1.6
ROA-2.42%
P/B Ratio-0.9
Op. Cash Flow$22.7M
Free Cash Flow$34.0M

Technical Analysis

TrendBearish
RSI57.7
Support$5.00
Resistance$8.09
MA 20$6.87
MA 50$6.92
MA 200$8.73
MACDBullish
VolumeIncreasing
Fear & Greed Index92.14

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.67
Volatility102.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.